pLenti_P2A_Puro Citations (1)

Originally described in: The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferent.
Middelburg J, Ghaffari S, Schoufour TAW, Sluijter M, Schaap G, Goynuk B, Sala BM, Al-Tamimi L, Scheeren F, Franken KLMC, Akkermans JJLL, Cabukusta B, Joosten SA, Derksen I, Neefjes J, van der Burg SH, Achour A, Wijdeven RHM, Weidanz J, van Hall T Cell Rep. 2023 Dec 26;42(12):113516. doi: 10.1016/j.celrep.2023.113516. Epub 2023 Dec 3. PubMed Journal

---

Articles Citing pLenti_P2A_Puro

Articles
CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognition. Schoufour TAW, van der Plas-van Duijn A, Derksen I, Melgers M, van Veenendaal JMF, Lensen C, Heemskerk MHM, Neefjes J, Wijdeven RHM, Scheeren FA. iScience. 2024 May 27;27(6):110120. doi: 10.1016/j.isci.2024.110120. eCollection 2024 Jun 21. PubMed

If you have published an article using this material, please email us at to have your article added to this page.